Phase I/II trial of reovirus in combination with cyclophosphamide in patients with advanced treatment-refractory solid tumours.

Trial Profile

Phase I/II trial of reovirus in combination with cyclophosphamide in patients with advanced treatment-refractory solid tumours.

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 09 May 2008

At a glance

  • Drugs Cyclophosphamide; Pelareorep
  • Indications Lung cancer; Ovarian cancer; Pancreatic cancer; Solid tumours
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 09 May 2008 Status changed from initiated to recruiting according to media release from Ocolytics Biotech.
    • 12 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top